The Effects of Fish Oil on Patients With Chronic Nonspecific Low Back Pain
NCT02774109 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29
Last updated 2018-06-07
Summary
Objectives:
To investigate the efficacy of omega-3 polyunsaturated fatty acids (PUFA) on patients with chronic nonspecific low back pain (NLBP).
Methods and Materials:
Twenty-nine patients with chronic NLBP were randomly divided into experimental and control groups. For 8 weeks, participants in the experimental group received omega-3 PUFA at 3000 mg/day plus physical therapy, while those in the control group received placebo plus physical therapy. The visual analog pain scale, pressure algometer, Biering-Sorenson test, Roland-Morris Low Back Pain and Disability Questionnaire (RMQ), and occupational burnout inventory (OBI) were used in assessments at baseline (T0) and after 4 (T1) and 8 weeks (T2). Serum erythrocyte sedimentation rate (ESR) and hypersensitive C-reactive protein (hs-CRP) were checked at baseline and T2.
Conditions
- Chronic Low Back Pain
Interventions
- DIETARY_SUPPLEMENT
-
Fish oil
Five 1000mg fish oil soft capsules per day (each capsule containing 350mg EPA and 250mg DHA) for 8 weeks
- DIETARY_SUPPLEMENT
-
Placebo
Five 1000mg sunflower oil soft capsules per day for 8 weeks
- PROCEDURE
-
Hotpacking
Hotpacking 15min on low back, three times a week for 8 weeks
- PROCEDURE
-
Transcutaneous electrical nerve stimulation (TENS)
Transcutaneous electrical nerve stimulation (TENS) 15min on low back, three times a week for 8 weeks
Sponsors & Collaborators
-
Chang Gung Memorial Hospital
lead OTHER
Principal Investigators
-
Tsung-Hsun Yang, MD · Kaohsiung Chang Cung Memorial Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-12-31
- Primary Completion
- 2017-11-30
- Completion
- 2017-11-30
Countries
- Taiwan
Study Locations
More Related Trials
-
The Effects of Omega-3 Fatty Acids Supplementation on Endothelial Function and Inflammation
NCT01310270 ·Status: COMPLETED ·Phase: NA
-
Effects of 12 Weeks of Omega 3 Supplementation on Resting Metabolic Rate
NCT02092649 ·Status: COMPLETED ·Phase: NA
-
Study of Metabolic Syndrome Use Omega-3 Fatty Acids and Low Fat Meal
NCT01768169 ·Status: UNKNOWN
-
The Use of Fish Oil to Reduce Inflammation Caused by a Peripheral Vascular Intervention
NCT02096757 ·Status: COMPLETED ·Phase: NA
-
Fish Gelatin Supplement and Omega-3 Supplement in Obese or Overweight Subjects With Insulin Resistance
NCT01215903 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Combined Fatty Acid Supplementation and Eccentric Exercise Training on Exercise Performance
NCT03259412 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study Regarding the Beneficial Effects of Omega-3 Fatty Acids on Cardiometabolic Health
NCT02042274 ·Status: COMPLETED ·Phase: NA
-
Impact of Omega-3 Fatty Acid Oral Therapy on Healing of Chronic Venous Leg Ulcers in Older Adults
NCT03576989 ·Status: COMPLETED ·Phase: NA
-
Effect of High Omega-3 Fish Intake on Lipid Peroxidation
NCT01183520 ·Status: COMPLETED ·Phase: NA
-
The Effects of Omega-3 Fatty Acids on Metabolic Syndrome
NCT00350194 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Fish Oil Supplementation, Resting Energy Expenditure, Skeletal Muscle Membrane Composition and Metabolism in Elderly Subjects.
NCT02338401 ·Status: UNKNOWN ·Phase: NA
-
Effects of Omega-3 Fatty Acids on the Human Gene Expression
NCT01089231 ·Status: COMPLETED ·Phase: PHASE4
-
Fish Oil-derived Omega-3 Fatty Acids on Gut Microbiota and Lipid Metabolome in Type 2 Diabetes Mellitus
NCT06061510 ·Status: COMPLETED ·Phase: NA
-
n-3 Polyunsaturated Fatty Acids to Prevent and Treat Diabetic Neuropathy
NCT05145452 ·Status: TERMINATED ·Phase: NA
-
Short Term Omega-3 Supplementation on Performance
NCT02014233 ·Status: COMPLETED ·Phase: NA
-
The Impact of Fish-oil Fatty Acids on Postprandial Vascular Reactivity
NCT01692431 ·Status: COMPLETED ·Phase: NA
-
Meta-analysis of Fish Oil Supplementation and Cardiovascular Outcomes in Diabetes
NCT04327713 ·Status: UNKNOWN
-
Intervention Study With Omega-3 Fatty Acids for Weight Loss and Insulin Resistance in Adolescents
NCT01456221 ·Status: COMPLETED ·Phase: NA
-
Vitamin D and n-3 Polyunsaturated Fatty Acids (PUFAs) to Prevent Chronic Pain Following Major Thermal Burn Injury
NCT03313076 ·Status: TERMINATED ·Phase: PHASE2
-
Comparison of EPA and DHA-Rich Fish Oils on Lipoprotein Metabolism In Adults
NCT02514070 ·Status: COMPLETED ·Phase: PHASE2
-
Fish Oil and Muscle Function
NCT01308957 ·Status: COMPLETED ·Phase: NA
-
Effect of Fish Oil on Insulin Sensitivity
NCT01241474 ·Status: COMPLETED ·Phase: NA
-
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
NCT04496154 ·Status: COMPLETED ·Phase: NA
-
The Effect of Omega-3 Supplementation on Muscle Functioning, Inflammation and Muscle Signaling
NCT03986307 ·Status: COMPLETED ·Phase: NA
-
Impact of n-3 Polyunsaturated Fatty Acids in a Protein-enriched Diet With Low GI in Type 2 Diabetes Patients
NCT01474603 ·Status: COMPLETED